Crossmark

Is the Prognostic Nutritional Index a Prognostic Marker for the Survival of Patients with Lymph-Node Positive Stage II-III Gastric Cancer Who Receive Adjuvant Chemotherapy?

Crossref DOI link: https://doi.org/10.1007/s12029-023-00972-x

Published Online: 2023-09-22

Published Print: 2023-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Korkmaz, Mustafa https://orcid.org/0000-0003-0926-6748
Eryılmaz, Melek Karakurt https://orcid.org/0000-0003-2597-5931
Er, Muhammed Muhiddin https://orcid.org/0000-0002-0583-0295
Koçak, Mehmet Zahid https://orcid.org/0000-0003-3085-7964
Demirkıran, Aykut https://orcid.org/0000-0002-2842-4695
Karaağaç, Mustafa https://orcid.org/0000-0003-4533-0620
Araz, Murat https://orcid.org/0000-0002-4632-9501
Artaç, Mehmet https://orcid.org/0000-0003-2335-3354
Koçak, Zahid Mehmet
License Information

Text and Data Mining valid from 2023-09-01

Version of Record valid from 2023-09-01
More Information

Article History

Accepted: 12 September 2023

First Online: 22 September 2023

Declarations

:

: This study was conducted retrospectively from data obtained for clinical purposes and was in line with the 1964 Declaration of Helsinki. This study was approved by Necmettin Erbakan University Research Ethics Committee (Approval number:2022/3974).

: Written informed consent was not obtained as the study was a retrospective study.

: The authors report there are no competing interests to declare.

Document is current

Any future updates will be listed below